-
Energy Dept. Awards Wind Power R&D Grants
The U.S. Department of Energy (DoE) is awarding more than $5 million to support wind energy development in the U.S., specifically to develop better forecasting tools and improve wind turbine technology. About two-thirds of the $5 million awarded will go for two projects to improve short-term wind forecasting, which can better integrate wind power into…
-
Water Purification Method Harnesses CO2 from Captured Carbon
Krebs & Sisler LP, a Winnetka, Illinois energy research firm, unveiled a method of purifying water using carbon dioxide (CO2), which the company proposes as a way of using the large amounts of CO2 captured in new “clean coal” technologies. The method, says Krebs & Sisler, also rapidly grows algae, that can be used as…
-
AstraZeneca, University to Collaborate on Stem Cell Therapies
AstraZeneca, a global pharmaceutical company, and University College London (UCL) today agreed to develop regenerative medicines for diabetic retinopathy (DR), enabled by stem cell research. Under the three-year agreement, AstraZeneca and scientists at the UCL’s Institute of Ophthalmology will collaborate to identify new therapeutic tools that take advantage of the regenerative capacity of stem cells.…
-
First Mobile Charging Station for Electric Cars Unveiled
Nation-E AG, a Swiss developer of energy storage, smart metering, and power load management solutions, launched today what it says is the world’s first mobile charging station. Dubbed the Angel Car, the new vehicle provides the technology for charging batteries of stranded electric cars and trucks while on the road. The company says that while…
-
Michigan Lithium Ion Battery Plant to Open Today
A123 Systems, a developer and manufacturer of battery systems, is opening today in Livonia, Michigan a new plant that the company says is the largest lithium ion automotive battery production facility in North America. The plant is expected to expand A123’s manufacturing capabilities by up to 600 megawatt hours per year when fully operational (1…
-
Novo Nordisk to Double China R&D Staff
Novo Nordisk, a Danish pharmaceutical company, said today it will expand its research and development staff in Beijing, China from 100 to 200 employees by 2015. The additional staff will initially work on new research involving diabetes. The company says its future research scope in China will be broadened to include pharmacological studies other than…
-
Solar Powered Water Purifier Developed for Disaster Relief
Spectra Watermakers Inc. in San Rafael, California, in collaboration with Trunz Water Systems, a Swiss company, has developed a self-contained water purification unit that can meet the needs of disaster relief efforts, such as those now in action in Pakistan. The Solar Container, as the unit is called, is powered by renewable solar or wind…
-
Russian Weapons-Grade Uranium Converted to Nuclear Fuel
USEC Inc., a supplier of enriched uranium fuel for commercial nuclear power plants in Bethesda, Maryland, says through its participation in the Megatons to Megawatts program, it has recycled 400 metric tons of weapons-grade uranium from Russia into low enriched uranium used as fuel in commercial nuclear power plants. This conversion of 400 metric tons…
-
Study IDs More Efficient Vaccine Supply Chain Processes
New research identifies potential processes for drug manufacturers and public health officials to reduce pediatric vaccine supply shortages and still maximize immunity from disease by children. Researchers at University of Illinois at Urbana-Champaign (UIUC) and Rochester Institute of Technology (RIT) in New York have developed a mathematical framework to better understand the implications of the…
-
Industry Report Lists Anti-Infection Drugs in Pipeline
The Pharmaceutical Research and Manufacturers of America (PhRMA) released today a report listing 395 new drugs designed to fight infections that are nearing the marketplace. Each of the drugs are either in clinical trials or under review by the U.S. Food and Drug Administration. More than one-third of the drugs on the PhRMA list —…